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Abstract 
Background: In Nigeria, only medical doctors, dentists and some nurses in primary care 
facilities have the legal right to prescribe medicines to patients. Patients’ access to prescription 
medicines can be seriously affected by the shortage of prescribers leading to longer waiting 
times in hospitals.  
Objective: This research was carried out to investigate stakeholders’ views on granting 
prescribing authority to pharmacists in Nigeria. 
Setting: The study was conducted in Nigeria 
Methods: Qualitative, semi-structured interviews were conducted with 43 Nigerian 
stakeholders including policymakers, pharmacists, doctors and patient group representatives. 
Transcribed interviews were entered into the QSR NVivo 10 software and analysed using a 
thematic approach.  
Main outcome measure: Stakeholders’ perception on the granting of prescribing authority to 
pharmacists in Nigeria. 
Results: Three major themes emerged from the interviews: 1) prescribing as a logical role for 
pharmacists, 2) pharmacist prescribing- an opportunity or a threat and 3) the potential barriers 
to pharmacist prescribing.  Many non-medical stakeholders including pharmacists and patient 
group representatives supported an extended role for pharmacists in prescribing while the 
majority of medical doctors including those in policy making were reluctant to do so. Generally, 
all stakeholders perceived that pharmacist prescribing represents an opportunity to increase 
patients’ access to medicines, reduce doctors’ workload and promote the utilisation of 
pharmacists’ skills.  However, many stakeholders including pharmacists and doctors 
commonly identified pharmacists’ inadequate skills in diagnosis, medical resistance and 
shortage of pharmacists as potential barriers to the introduction of pharmacist prescribing in 
Nigeria. 
Conclusion: The present study showed a split of opinion between participants who were 
medical doctors and those who were non-doctors in their support for pharmacist prescribing. 
However, all stakeholders acknowledged the potential of pharmacist prescribing to increase 
patients’ access to medicines in Nigeria.  
Keywords: pharmacist prescribing; access to medicines; physicians; pharmacists; 
policymakers; patient representatives; Nigeria 
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Impact of findings on practice 
• Patients’ access to prescription medicines can be seriously affected by the shortage 
of prescribers in Nigeria. 
• Pharmacists in Nigeria are highly educated professionals whose skills have been 
underutilised. 
• Pharmacist prescribing offers an opportunity to increase patients’ access to medicines 
in Nigeria and promote the utilisation of pharmacist skills. 
 
Introduction 
To prescribe is to “authorize by means of a written prescription the supply of a medicine” [1 
p.11]. Prescribing to patients was the exclusive role of doctors and dentists, until the 
introduction of non-medical prescribing (NMP) in some countries which allowed non-medical 
professionals including nurses and pharmacists to prescribe medicines [2, 3]. A number of 
countries have legislated for NMP including the United States of America (USA), United 
Kingdom (UK), Australia, New Zealand, Canada, Sweden, Republic of Ireland, South Africa, 
Botswana, Kenya and Uganda [4]. Nurse prescribing is the most popular form of NMP.  
Available data shows that Nurses have been authorised to prescribe in 22 countries [4]. 
Pharmacist prescribing is increasingly being accepted and implemented in many developed 
countries. Pharmacists currently have the legal right to prescribe medicines in the USA, UK, 
Canada, New Zealand and Israel [5-7]. The increase in the international recognition of 
pharmacist prescribing has been facilitated by the desire to ensure prompt patients’ access to 
prescription medicines and better utilisation of pharmacists’ skills  [8]. 
Nevertheless, in many developing countries including Nigeria, where access to medicines has 
remained a public health challenge due to shortage of medical prescribers, pharmacist 
prescribing is yet to be recognised as an important strategy that would enhance patients’ 
access to medicines. The legislation concerning prescribing of medicines in Nigeria states that: 
“In tertiary and secondary health care institutions, only duly qualified and 
licensed medical practitioners shall have the authority to prescribe drugs. At 
the primary health care level, government shall designate appropriate health 
care personnel to prescribe drugs; only qualified and licensed medical 
practitioners shall have the authority to prescribe drugs in the private sector” 
[9 p.25]. 
Hence, only medical doctors and dentists have the legal right to prescribe medicines to 
patients in Nigeria, except in primary health centres (PHCs). Since most PHCs lack doctors, 
prescribing is mostly done by nurses and community health workers using standing orders or 
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protocols [10, 11]. However, a number of concerns exist in terms of the safety of prescribing 
by nurses and community health workers because of their lack of adherence to treatment 
guidelines and inadequate knowledge of medicines [10, 12, 13].  
Therefore, the general out-patient department (GOPD) of hospitals in Nigeria is usually the 
entry points for most patients seeking medical help because of the lack of doctors in PHCs 
[14, 15]. Because of this lack of doctors, a doctor in a GOPD in Nigeria has approximately 40 
– 50 patient consultations per day [16, 17]. There are about 40 doctors per 100,000 people in 
Nigeria compared with 280 doctors per 100,000 people in the UK including general 
practitioners and specialist physicians [18]. Furthermore, more than 50% of patients visiting 
GOPDs wait for between one to three hours to see a doctor [16, 17, 19].  Thus, it is beyond 
doubt that the current prescribing arrangements in Nigeria do not sufficiently meet the needs 
of patients in terms of timely and convenient access to prescriptions.  
Pharmacists in Nigeria are highly educated professionals with expertise in medicines 
management. Their mode of training follows similar models in advanced countries including 
the UK [20]. It consists of a five-year undergraduate professional programme followed by a 
one-year pre-registration work-based supervised training [20]. In addition, many pharmacists 
in Nigeria are specialising as clinical pharmacists at various universities and the West African 
Postgraduate College of Pharmacists [21]. Despite the cost and high level of training of 
pharmacists in Nigeria, their expertise is not used effectively as their roles have not been 
expanded to a more clinical one. They mainly perform the traditional role of dispensing, which 
could be handled by suitably trained pharmacy technicians as in other countries such as the 
UK [22].   
Pharmacists in Nigeria have shown a willingness for expanded clinical roles including 
prescribing [23, 24]. In addition, a pilot survey conducted among clients of community 
pharmacists in a city in Nigeria has revealed a high support for pharmacist prescribing [25]. 
However, no research has explored the views of other key stakeholders including 
policymakers, leaders of professional medical and pharmacy groups, who are the major 
players in driving medicines policies in Nigeria. Therefore, this necessitated this research to 
explore the opinions of various stakeholders involved in medicines prescribing on the potential 
for pharmacist prescribing in Nigeria.  
Aim of the study 
This study was carried out to explore the views of stakeholders involved in prescribing and 
pharmacy practice on the extension of pharmacists’ clinical roles to include prescribing in 
Nigeria. 
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Ethics approval 
This study required and received ethics approval from the School of Healthcare Research 
Ethics Committee, University of Leeds, UK and the Plateau State Specialist Hospital Health 
Research Ethics Committee, Nigeria. All participants were provided with an information sheet 
containing details of the research and written or oral, informed consent was obtained from 
them. 
Methods 
Using a purposeful sampling technique employing maximum variation in order to obtain a 
range of perspectives (mix of stakeholders, practice and geographical settings), generic 
recruitment emails were sent to 134 prospective participants. These included heads of 
pharmacy and medical departments in some secondary and tertiary hospitals; leaders of 
professional pharmacy and medical associations including the Pharmaceutical Society of 
Nigeria and Nigerian Medical Association; directors of pharmaceutical and medical 
departments at the State and Federal Ministry of Health; academics and patient group 
representatives. A total of 43 stakeholders who accepted to participate in the study were 
interviewed. 
Qualitative semi-structured telephone interviews were conducted from April to June 2014. 
Telephone interviews were employed to enable the interviewing of a range of stakeholders 
across many locations in Nigeria. The interview guide was based on a study conducted in 
England and the review of the literature [22]. Pharmacist prescribing from the perspective of 
this research was introduced to participants to mean the granting of pharmacists the `legal 
authority to prescribe ‘Prescription Only Medicines’ as currently practised by doctors in Nigeria 
which differs from counter prescribing or the supply of over the counter medicines as currently 
practised by community pharmacists in response to patients’ complaints or symptoms. Topic 
areas covered included participants’ perception of pharmacist prescribing, reservations 
concerning pharmacist prescribing, potential facilitators and barriers to pharmacist prescribing 
in Nigeria, advantages associated with pharmacist prescribing and the potential changes in 
the structure of pharmacy that would be needed for the development of pharmacist prescribing 
in Nigeria. The interviews conducted lasted between 20 to 70 minutes. Data saturation was 
achieved when further interviews did not yield any new thematic information and this was 
perceived to be reached at about the 35th interview. However, further interviews were carried 
out with the remaining eight stakeholders who accepted to participate in the study. 
The interviews conducted were digitally recorded and fully transcribed. One researcher 
checked each transcript against the digital audio recording for accuracy. Transcript data were 
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entered into the QSR NVivo 10 software for appropriate data management. Data were 
analysed using thematic analysis in the manner outlined by Braun and Clarke [26]. The 
analysis proceeded in iterative stages of data familiarisation, generation of codes, searching, 
reviewing, defining and naming of themes. The data were independently coded and analysed 
by one researcher but reviewed at different stages by two additional researchers including 
reviewing and refining the coding structure and identified themes. At the final stage of the 
analysis, identified themes were discussed by the three researchers until a consensus was 
reached. 
Results 
Demographics  
The 43 stakeholders interviewed comprised of 20 pharmacists, 9 doctors, 11 policymakers, 
and 3 patient group representatives. These participants were drawn from the six geopolitical 
regions of Nigeria. The 11 policymakers interviewed were from the federal (5) and state (6) 
levels. The 20 pharmacists who participated in this study included 4 academics, 5 community 
pharmacists and 11 hospital pharmacists; while the 9 doctors were 4 consultants, 3 residents, 
and 2 general practitioners.  The pharmacists interviewed had from 5 to 37 years of experience 
while the doctors had from 10 to 37 years of experience. Eight (8) of the participants 
interviewed were practising in secondary hospitals located in rural centres. 
Views on pharmacist prescribing 
Three themes emerged from stakeholders’ views on pharmacist prescribing in Nigeria:  
1. Prescribing as a logical role for pharmacists  
2. Pharmacist prescribing- an opportunity or a threat  
3. The potential barriers to pharmacist prescribing  
These themes are reported below.  
Prescribing a logical role for pharmacists 
Generally, opinions were split between pharmacists and doctors concerning pharmacist 
prescribing. Pharmacists were generally in support of a prescribing authority for them. They 
saw it as a logical role for pharmacists given their knowledge of medicines.  
 “But we know when we go to the hospitals, let say a general hospital in the 
rural area, the prescribers really are not doctors, they are either senior nursing 
or community health officers. So why not allow the pharmacists to also 
prescribe, more so that he knows the drugs and now with his training [clinical] 
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he knows some of the diseases with their clinical features.” P26, Academic 
Pharmacist 
Some community pharmacists reported that they do counter prescribing in response to 
patients’ complaints and therefore saw prescribing as a natural progression of their roles. 
 “I attend to patients. They come with minor ailments and I treat them. So, I 
don’t see prescribing as a difficult thing to do.” P08, Community Pharmacist 
Similarly, a hospital pharmacist interviewed also considered prescribing as a natural 
progression of hospital pharmacists’ roles. This pharmacist reported that they work 
collaboratively with doctors to influence doctors’ prescribing. 
“Sometimes we suggest to the doctor what to prescribe. So, what is stopping 
us from prescribing?” P18, Hospital Pharmacist 
However, many doctors were non-supportive of a prescribing role for pharmacists.   
“On a personal note I think pharmacists should not prescribe. I think it is not 
part of their job, they shouldn’t prescribe.” P29, Resident Doctor 
Interviews held with policymakers also reiterated the split of views observed between doctors 
and pharmacists as policymakers views were aligned to their professional background.  
“In my own opinion, I think they [pharmacists] are well equipped to be granted 
the right to prescribe. P27, Policymaker with a pharmacy background 
“No, no, no, no, I don't support that. Any person that should be allowed to give 
a prescription should be a medical doctor but for a pharmacist to be a 
prescriber, I don’t support that.”  P36, Policymaker with a medical background 
Despite many doctors’ lack of support to pharmacist prescribing, a few of them reported that 
granting some form of prescribing authority to pharmacists will be a logical thing to do. 
“You know, hospital facilities are not everywhere. Given our health challenges, 
there is need to empower pharmacists to be able to do more than they are 
doing at the moment.” P17, General Practitioner 
Furthermore, patient group representatives interviewed also felt that prescribing would be a 
reasonable role for pharmacists and were supportive of pharmacist prescribing. 
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“Why not? Even nurses who do not have the amount of knowledge that 
pharmacists have on drugs, prescribe. So why can’t the pharmacist 
prescribe?” P38, Patient group representative 
Potential barriers to pharmacist prescribing 
Participants identified a number of factors that could hinder the introduction of pharmacist 
prescribing in Nigeria. Many participants including doctors, pharmacists, policymakers and 
patient group representatives expressed concern over pharmacists’ skills in diagnosis. They 
saw that as a potential barrier. 
 “Yeah, the concern about pharmacist prescribing will arise basically from the 
fact that the competence to be able to make accurate diagnosis is critical in 
therapy.” P17, Medical doctor 
However, if pharmacists are to prescribe in collaboration with doctors as suggested by many 
participants, the concern of pharmacists’ inadequate skills in diagnosis would be taken care 
of.  
“I think in Nigeria the best way for now is to do it in collaboration with a doctor 
because they are trained to diagnose.” P11, Hospital Pharmacist 
Nevertheless, participants observed that collaborative prescribing will only be practicable in 
hospital settings where doctors and pharmacists work together in patient care. They reported 
that this is unlikely in community pharmacy settings given that there is currently no structure 
in place that allows community pharmacists to work in partnership with doctors.  
Generally, resistance from the medical profession was cited as a fundamental barrier to 
pharmacist prescribing in Nigeria. Participants felt that such resistance is expected because 
doctors would react in such a way to protect their territory.  
“If you tell Nigerian doctors to relinquish what they see as their birth right to 
another professional, there will be serious opposition” P03, Pharmacist 
Many pharmacists felt that medical resistance is likely to occur at policy level because of the 
overriding dominance of doctors in the leadership structure of health sector. 
“If you look at the federal and state ministry of health, the top hierarchies are 
occupied by doctors. So, policy wise there is also a barrier.” P32, Policymaker 
Another major barrier mentioned was the shortage of pharmacists in many hospitals.  
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 “So, hospital pharmacists are overwhelmed by the traditional pharmacy 
responsibilities of dispensing medications and procuring drugs.  So, they may 
not have the time to do an additional role but if they are more in number that 
will be facilitated.” P26, Pharmacist 
There were concerns that pharmacist’s attitude in taking up extended clinical roles could be a 
possible barrier to pharmacist prescribing as mentioned by a participant below. 
“Pharmacists’ attitude is usually a big barrier. Some pharmacists are very 
comfortable with those traditional roles, they don’t want to acquire new skills, 
and they don’t want to move into different areas where pharmacists are 
needed in clinical practice and all that.” P05, Pharmacists 
However, the popular view held by many pharmacists indicated that many of them are 
unsatisfied with their current roles and were willing to expand their roles clinically. Such 
willingness for role expansion could be a driver to extended role in prescribing.  
“Yes, the younger pharmacists are willing to expand their roles clinically, even 
some older ones too. The younger pharmacists because of their mode of 
training they see themselves as being under-utilised.” P16, Pharmacist 
Furthermore, some participants expressed concern that community pharmacists may have 
conflict of interest in their prescribing since many community pharmacies were established on 
a business model. 
“If the pharmacist is allowed to prescribe in his community pharmacy, there 
will be a lot of problems because the pharmacist will only be interested in the 
patient buying his drugs and this can bias his prescription.” P06, Pharmacist 
Also, some participants mentioned that community pharmacists may not have access to 
patients’ medical records and adequate facilities that would support their prescribing practice.  
Pharmacist prescribing: an opportunity or a threat 
While many participants saw the granting of prescribing authority to pharmacists as beneficial; 
others perceived it as a threat.  
Generally, there was a perception among many stakeholders that allowing pharmacists to 
prescribe could improve patients’ access to treatment and reduce waiting time.  
“You see, in some facilities there are no doctors at all. Allowing pharmacists 
to prescribe will go a long way.” P24, Patient group representative 
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“The patient time will be saved because the patient will not have to wait all 
day waiting for a doctor’s prescription” P2, General Practitioner 
A participant also noted that it will increase the options in which patients have to seek 
treatment from different professionals, thereby empowering the patient. 
“You will have more experts prescribing to patients rather than just the doctor.” 
P27, Policymaker  
Participants, particularly pharmacists observed that pharmacist prescribing will promote the 
utilisation of pharmacists’ skills, make pharmacists job more satisfying and enhanced 
pharmacists’ professional status.  
 “Definitely, there will be job satisfaction on the part of the pharmacists. I am 
very, very satisfied doing clinical work.” P05, Hospital Pharmacist  
A medical doctor also expressed similar view on the potential benefit to the pharmacy 
profession. 
“I think it will be a lot of fun for them. Pharmacists will be able to have patients 
that they treat from beginning to the end of the disease process all on their 
own and that will be quite an exciting experience and might inspire them to 
be even more professional about their practice and of course the satisfaction 
they will derive from all of that I think all will add up to improving perhaps the 
practise so to say of the pharmacist in the public eye.” P17, General 
Practitioner 
There was a general view among all stakeholders that pharmacist prescribing in Nigeria could 
reduce doctors’ workload and free them up to concentrate on other specialised tasks 
 “It will take the pressure off the general practitioner which means that the 
doctors will now concentrate on more delicate issues of diagnosis instead of 
having to be battling with minor illness.” P31, Policymaker  
However, some participants particularly doctors viewed pharmacist prescribing as an 
encroachment into doctors’ professional boundary as prescribing has always been the doctors’ 
role in Nigeria. Therefore, these doctors responded in such a way to preserve this boundary.  
“No, I will not support pharmacists prescribing. They should do their own work. 
Prescription is under the boundary of the medical doctors. I mean it is one of 
the main things we have as doctors, by the time every other person prescribes, 
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then what does the doctor really do? So, that will be like taking our jobs from 
us.” P33, Policymaker and Medical Doctor 
Furthermore, a few pharmacists were concerned that pharmacist prescribing might result in 
the loss of the exclusive right they have over dispensing. They fear that doctors are likely to 
seek for some dispensing authority if pharmacists are allowed to prescribe.  
“… if we pursue that objective, the doctors too may want to say let us too have 
some dispensing role which is traditionally the function of the pharmacists.” 
P03, Hospital Pharmacist 
This concern was expressed by pharmacists who viewed dispensing as a key role that 
maintains pharmacists’ professional status. 
Discussion 
This study showed a split of opinion between participants who were medical doctors and those 
who were non-doctors. While many non-medical stakeholders interviewed including 
pharmacists and patient group representatives supported an extended role for pharmacists in 
prescribing, many medical doctors including those in policy making were reluctant to do so.  
Many pharmacists interviewed, including those who are policymakers considered prescribing 
as a logical role for pharmacists considering pharmacists’ knowledge in therapeutics. This 
knowledge they considered essential for prescribing. However, prescribing is a complex 
process that encompasses identifying patients’ problem; specifying treatment objectives; 
determining the safe and cost-effective treatment; instituting and monitoring patients’ therapy 
[27]. These processes involve the use of the prescribers’ knowledge and skills in diagnosis 
and therapeutics to make informed clinical decisions concerning patients’ therapy [28]. Unlike 
the medical practitioners’ training, pharmacists’ basic training is limited in clinical assessment 
and diagnosis. In many countries where pharmacists are legally allowed to prescribe including 
the UK and New Zealand additional training is provided to prepare pharmacists for prescribing 
[3, 28]. The training incorporates applied therapeutics and differential diagnosis; and a period 
of learning in practice under a medical mentor [3].  In addition, these countries implemented a 
collaborative form of prescribing initially which does not require the pharmacist to make 
diagnostic decisions. Therefore, a collaborative form of prescribing, as suggested by 
participants of this study would be good for initial implementation in Nigeria. This form of 
prescribing would appeal to doctors as the  diagnosis, overall patient management and initial 
treatment decisions remain with the medical prescriber [28]. Also, certain benefits are likely to 
be associated with a collaborative prescribing in Nigeria. It will foster collaboration between 
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doctors and pharmacists and provide the prescribing pharmacist the opportunity to learn from 
the medical prescriber especially in the aspect of diagnosis. The experience gained could be 
instrumental if independent prescribing is subsequently implemented. 
Generally, many medical doctors were unsupportive for pharmacist prescribing because 
prescribing in Nigeria is under their jurisdiction. Therefore they viewed pharmacist prescribing 
as an encroachment into medical territory and a challenge to medical dominance. This finding 
is unsurprising because similar attitudes were shown by medical doctors in other countries 
including South Africa and Canada where pharmacists have attempted to expand their roles 
to include prescribing [29, 30]. Doctors in these countries responded in such a way to protect 
their professional territory from encroachment [29, 30]. The general behaviour of medical 
doctors could be explained by the sociological theory that posit that prescribing is a core role 
that confers clinical autonomy to medical doctors and also grants them control over the role of 
other healthcare professionals [31, 32]. For example, a pharmacist’s role of dispensing is 
dependent on an instruction (prescription) from a doctor. This therefore puts the medical 
doctor in control of the work sphere of the pharmacist [32]. Hence, the fear of the loss of this 
control could account for doctors’ non-support for pharmacist prescribing. 
A major factor that gained support for pharmacist prescribing among participants was the 
potential benefits associated with it. Patient group representatives were very supportive of a 
prescribing authority for pharmacist because they perceived it will promote quick and 
convenient access to treatment. Other stakeholders including medical doctors and 
policymakers also acknowledged that pharmacist prescribing could potentially increase 
patients’ access to treatment in Nigeria. Increasing patients’ access to care while maintaining 
patient safety has primarily been the driver for NMP including pharmacist prescribing in many 
countries where it has been introduced [1, 33].  Many research reports from the UK have 
indicated that patients’ access to treatment has been enhanced as a result of non-medical 
prescribing [34, 35]. This would be of great benefit to patients in Nigeria. For example, about 
110 million malaria cases are clinically diagnosed annually in Nigeria and uncomplicated 
malaria accounts for about two-thirds of outpatient visits in hospitals [36]. As mentioned earlier, 
more than 50% of out-patients wait for between one to three hours to see a doctor as a result 
of shortage of medical prescribers [16, 17, 19]. Therefore, authorizing pharmacists to clinically 
diagnose and prescribe for patients with uncomplicated malaria could provide prompt access 
to malaria treatment. However, given pharmacists inadequate skills in diagnosis, additional 
training would be needed. Hence, this study was followed-up with a survey conducted among 
Nigerian pharmacists to determine their areas of training needs in order to take on a 
prescribing role.  
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Community pharmacists in Nigeria appear to be well positioned for prescribing considering 
their accessibility especially in urban areas, current counter prescribing practice and the 
reliance on them by members of the public for their treatment needs [25]. However, introducing 
prescribing in community pharmacies is subject to a number of challenges. These include lack 
of collaboration between community pharmacists and doctors and lack of access to patients’ 
clinical records since there is no structure in place that would facilitate exchange of patients’ 
clinical data between community pharmacies and hospitals. Therefore, a prescribing model 
likely to be successful in Nigerian community pharmacies is a limited form of independent 
prescribing using approved formularies or standard treatment guidelines for minor conditions. 
This was the type of prescribing model community pharmacists were authorised to do in South 
Africa in order to fill geographical gaps in relation to access to medical prescriber in rural 
settings [37]. Previous studies in Nigeria have advocated policy change to allow community 
pharmacists to treat minor disease conditions in Nigeria [25, 38]. Hence, utilising community 
pharmacists to provide primary healthcare in a similar manner to South Africa, offers an 
opportunity to increase patients access to care particularly in communities underserved by 
primary health centres. It also offers the opportunity to revitalise the current primary health 
care system in Nigeria which has been described as ineffective, and could serve as an 
incentive for community pharmacies presence in rural areas [37, 39]. Nevertheless, additional 
training would be needed to prepare community pharmacists to independently diagnose and 
treat disease conditions using standard treatment guidelines at the primary healthcare level.  
Other barriers to pharmacist prescribing identified were organisational including shortage of 
pharmacists and pharmacists’ lack of time to take on additional role. This is unsurprising 
considering that there are approximately 17,000 pharmacists in Nigeria which represents 
about 10 pharmacists to 100,000 people [40]. However, evidence from England suggests that 
utilising trained pharmacy technicians in some medicine supply roles of pharmacists, could 
free up pharmacists’ time for extended clinical roles including prescribing [22]. This may 
represent a feasible option to address pharmacists’ shortage and lack of time to do extended 
clinical roles in Nigeria. 
This study has a number of limitations. First, the study employed telephone interviews which 
have certain limitations including their inability to observe non-verbal communication. However, 
the use of telephone interviews enabled the interviewing of participants across many locations 
in Nigeria. In addition, the quality and depth of data obtained was not compromised since the 
researcher was experienced in telephone interviews and data collection continued until 
saturation was reached. Secondly, being a qualitative study, the findings of this study cannot 
be statistically generalised. In addition, a small number of patient group representatives and 
general practitioners participated in the study. Therefore, we followed up this study with a 
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quantitative survey to make our findings generalisable. Thirdly, one of the researchers in this 
study is a Nigerian pharmacist, who is to a large extent, experienced with pharmacy practice 
in Nigeria. This experience might have influenced key decisions made regarding this study 
including study aim and data interpretations. However, deliberate steps were taken including 
the triangulation of data sources and peer-reviewing of identified themes and data 
interpretations in order to ensure the ‘trustworthiness’ of the research. Finally, this study has 
provided avenues for future research including how best to: prepare pharmacists for a 
potential role in prescribing and promote collaboration between community pharmacists and 
doctors in Nigeria.  
Conclusion 
In conclusion, even though this study shows a difference in opinions among stakeholders 
regarding pharmacist prescribing, it clearly indicates that pharmacist prescribing would be well 
supported by many stakeholders including pharmacists and patients in Nigeria.  In addition, 
our study reveals that pharmacist prescribing represents an opportunity to increase patients’ 
access to treatment and the utilisation of pharmacists’ skills in Nigeria. Nevertheless, a number 
of potential barriers that could hinder the introduction of pharmacist prescribing in Nigeria were 
identified including pharmacist inadequate skills in diagnosis, medical resistance and shortage 
of pharmacist.   
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